The Health News USA December 16 2017

  • Eli Lilly on Wednesday forecast 2018 earnings and revenue largely above analysts’ estimates in part due to strong demand for recently launched diabetes drug Trulicity and psoriasis drug Taltz. The company said it expected 2018 revenue of $23.0 billion to $23.5 billion and adjusted earnings of $4.60 to $4.70 per share.
  • Two California biomedical firms named in an undercover video investigation of the sale of fetal tissue from abortions are shutting down after reaching a $7.8 million settlement with the Orange County District Attorney’s Office. As part of the settlement, DV Biologics LLC and sister company DaVinci Biosciences LLC were ordered to cease all operations in California within 60 to 120 days and admit liability for unlawfully selling fetal tissues and cells for profit.
  • Mayor Ed Lee, the city’s first Asian American mayor and the man who presided over San Francisco’s transformation during the recent tech boom, died early Tuesday morning after suffering a heart attack. He was 65. Lee collapsed while shopp ing at the Safeway grocery store on Monterey Boulevard near his Glen Park home at about 10 p.m. Monday and was taken by ambulance to San Francisco General Hospital. He died at 1:11 a.m., surrounded by friends and family.

News on Health Professional Radio. Today is the 16th of December 2017. Read by Tabetha Moreto.

https://www.cnbc.com/2017/12/13/lilly-forecasts-2018-profit-and-revenue-largely-above-estimates.html

Eli Lilly on Wednesday forecast two thousand eighteen earnings and revenue largely above analysts’ estimates in part due to strong demand for recently launched diabetes drug Trulicity and psoriasis drug Taltz. The company said it expected two thousand eighteen revenue of twenty three billion dollars to twenty three point five billion and adjusted earnings of four dollars and sixty cents to four dollars and seventy cents per share.

Lilly has been facing the threat of competition for some of its newer drugs including Taltz.
The U.S. Food and Drug Administration on Monday approved Sanofi SA’s Admelog as the first follow-on biologic version of Lilly’s top-selling insulin product, Humalog. Lilly reaffirmed its expectation of at least five percent average annual revenue growth from two thousand fifteen to two thousand twenty, on a constant currency basis. The company also lowered its two thousand seventeen earnings forecast to one dollar and fifty six cents to one dollar and sixty six, due to asset impairment, restructuring and other charges. It restated its two thousand seventeen adjusted earnings forecast of four dollars and fifteen cents to four dollars and twenty five cents per share.

https://www.washingtontimes.com/news/2017/dec/12/fetal-tissue-firms-undercover-pro-life-investigati/

Two California biomedical firms named in an undercover video investigation of the sale of fetal tissue from abortions are shutting down after reaching a seventeen point eight million dollar settlement with the Orange County District Attorney’s Office. As part of the settlement, DV Biologics Limited Liability Company and sister company DaVinci Biosciences Limited Liability Company were ordered to cease all operations in California within sixty to one hundred twenty days and admit liability for unlawfully selling fetal tissues and cells for profit.
….
Prosecutors opened the investigation into the fetal tissue companies in two thousand fifteen after undercover videos released by the pro-life Center for Medical Progress showed top Planned Parenthood executives and others in the abortion industry discussing the market for the human remains from abortions. David Daleiden, CMP project leader, praised prosecutors for shuttering the biomedical firms and called on them to investigate Planned Parenthood’s role in the operation.

….
The District Attorney’s Office said DaVinci Biosciences and DV Biologics had a revenue-driven business model that included an advertising campaign and marketing materials including a catalog of products available for sale.

Products derived from fetal lungs ranged in price from three hundred dollars to three hundred seventy five, fetal kidney-derived products from three hundred dollars to forty hundred fifty dollars, fetal heart-derived products from five hundred dollars to seven hundred fifty, and fetal liver-derived products from two hundred fifty dollars to seven hundred dollars. The biomedical firms unlawfully sold products derived from fetal tissue and cells to buyers in Japan, China, Singapore, Korea, Germany, Switzerland, Spain, Australia, Netherlands, Canada and the United Kingdom.

https://www.sfgate.com/news/article/San-Francisco-Mayor-Ed-Lee-dead-at-65-12423708.php

Mayor Ed Lee, the city’s first Asian American mayor and the man who presided over San Francisco’s transformation during the recent tech boom, died early Tuesday morning after suffering a heart attack. He was sixty five. Lee collapsed while shopping at the Safeway grocery store on Monterey Boulevard near his Glen Park home at about ten p.m. Monday and was taken by ambulance to San Francisco General Hospital. He died at one eleven a.m., surrounded by friends and family.

The mayor’s office released a brief statement early Tuesday morning confirming Lee’s death, stating in part: “Our thoughts and prayers are with his wife Anita, his two daughters, Brianna and Tania, and his family.” Flags at City Hall were lowered to half staff. News of Lee’s unexpected death shocked and saddened city officials, many of whom respected the moderate mayor even when he was their political adversary.
….
Several of Lee’s family members, including his wife and two daughters, returned to the mayor’s home in a quiet Glen Park cul-de-sac about eleven a.m. Lee’s wife walked quickly into the house, wearing sunglasses and looking down. One of Lee’s daughters, Tania, would only say, “We just need some time” before entering the house.

Liked it? Take a second to support healthprofessionalradio on Patreon!

0 Comments

Leave a Reply

You must be logged in to post a comment.